Physician profile
Layson L Denney
NPI 1457798399
$6,611.78
in general payments reported to CMS, 2019-2025
26 companies · $419 in 2025
The $419 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,475 · 2020: $158 · 2021: $691 · 2022: $163 · 2023: $510 · 2024: $196 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,208.29 | 2019-2023 | |
| Abbvie INC. | $911.32 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $294.10 | 2023-2025 | |
| Amgen INC. | $174.43 | 2019-2022 | |
| Medical Device Business Services, INC. | $149.03 | 2025 | Harmonic |
| Hologic Sales and Service, LLC | $144.22 | 2023-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Gynesonics, INC. | $143.53 | 2021 | |
| Astellas Pharma US INC | $120.99 | 2021-2025 | Veozah |
| Daiichi Sankyo INC. | $84.85 | 2021-2022 | |
| Ethicon US, LLC | $60.31 | 2025 | Dermabond |
| Evofem Biosciences, INC. | $41.43 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.89 | 2023 | |
| Convatec INC. | $29.01 | 2025 | |
| Organon LLC | $24.70 | 2023-2025 | Nexplanon |
| Lilly USA, LLC | $23.04 | 2025 | Zepbound |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22.02 | 2020 | |
| Innovation Technologies INC | $19.90 | 2024 | Irrisept |
| Takeda Pharmaceuticals U.S.A., INC. | $19.72 | 2021 | |
| Channel Medsystems, INC. | $15.73 | 2025 | |
| Sage Therapeutics, LLC | $14.47 | 2025 | Zurzuvae |
| Radius Health, INC. | $14.36 | 2019 | |
| Axonics, INC. | $14.26 | 2021 | |
| Novo Nordisk INC | $14.16 | 2022 | |
| Pfizer INC. | $13.34 | 2023 | |
| Myovant Sciences INC. | $12.32 | 2022 | |
| Aspira Women'S Health INC | $11.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Layson Denney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.